The influence of targeted education on medication persistence and generic substitution among consumer-directed health care enrollees
- PMID: 19780849
- PMCID: PMC2796315
- DOI: 10.1111/j.1475-6773.2009.01023.x
The influence of targeted education on medication persistence and generic substitution among consumer-directed health care enrollees
Abstract
Objective: To evaluate an educational outreach among consumer-directed health plan (CDHP) enrollees on medication persistence and lower-cost generic substitution within four chronic medication therapies.
Study setting: A cross-sectional analysis using pharmacy claims data from a national employer group that began offering a CDHP in 2006 and implemented an educational outreach to some CDHP enrollees in 2007 was used.
Methods: The intervention group was comprised of CDHP enrollees who received education outreach and was compared with CDHP enrollees without the educational outreach. Adjusted and unadjusted medication persistence and lower-cost generic substitutions were compared between groups.
Principal findings: There was no difference in medication persistence between groups. CDHP enrollees with the educational outreach were more likely to have converted to lower-cost generic alternative antihypertensive medication compared with CDHP enrollees without the educational outreach (OR(adj)=29.82, 95 percent CI=4.41-201.93).
Conclusion: Educational outreach directed to CDHP enrollees was associated with increases in lower-cost generic alternatives with no change in patients' chronic medication use. However, considerable opportunity exists to assist CDHP enrollees in making sound health care decisions.
References
-
- Buntin MB, Damberg C, Haviland A, Kapur K, McDevitt R, Marquis MS. Consumer-Directed Health Care: Early Evidence about Effects on Cost and Quality. Health Affairs. 2006;25:w516–30. - PubMed
-
- Claxton G, Gabel JR, DiJulio B, Pickreign J, Whitmore H, Finder B, Jarlenski MM, Hawkins S. Health Benefits in 2008: Premiums Moderately Higher, While Enrollment in Consumer-Directed Plans Rise in Small Firms. Health Affairs. 2008;27(6):w492–502. - PubMed
-
- Conlin PR, Gerth WC, Fox J. Four-Year Persistence Patterns among Patients Initiating Therapy with Angiotensin II Receptor Antagonist Losartan versus Other Antihypertensive Drug Classes. Clinical Therapuetics. 2001;23:1999–2010. - PubMed
-
- Cox ER, Kulkarni A, Henderson R. Impact of Patient and Plan Design Factors on Switching to Preferred Statin Therapy. Annals of Pharmacotherapy. 2007;41:1946–53. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
